Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese

Brain

Volumn 130, Issue 5, 2007, Pages 1206-1223

  Matsuoka, Takeshi ^a   Matsushita, Takuya ^a   Kawano, Yuji ^a   Osoegawa, Manabu ^a   Ochi, Hirofumi ^a   Ishizu, Takaaki ^a   Minohara, Motozumi ^a   Kikuchi, Hitoshi ^a   Mihara, Futoshi ^a   Ohyagi, Yasumasa ^a   Kira, Jun Ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Aquaporin 4; Japanese; Neuromyelitis optica; NMO IgG; Opticospinal multiple sclerosis

Indexed keywords

AQUAPORIN 4; AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; IMMUNOGLOBULIN G; INTERFERON BETA SERINE; METHYLPREDNISOLONE; PROTEIN ANTIBODY;

ADULT; ARTICLE; AUTOIMMUNITY; BLOOD SAMPLING; BRAIN DAMAGE; BRAIN STEM; CELL STRAIN HEK293; CERVICAL SPINAL CORD; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DEPRESSION; DRUG ERUPTION; DRUG MECHANISM; DRUG MEGADOSE; DRUG WITHDRAWAL; EMBRYO; FEMALE; GENDER; GENETIC HETEROGENEITY; GENETIC TRANSFECTION; GRAY MATTER; HOSPITAL; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOFLUORESCENCE; IMMUNOTHERAPY; INJECTION SITE PAIN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MYELOOPTIC NEUROPATHY; NEUROLOGIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; RELAPSE; SENSITIVITY AND SPECIFICITY; SERUM; SPASTICITY; SPINAL CORD LESION; THORACIC SPINAL CORD; TREATMENT RESPONSE; VERTEBRA; VISUAL SYSTEM; WHITE MATTER; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; CELL LINE; CONFOCAL MICROSCOPY; DISEASE COURSE; GENETICS; IMMUNOLOGY; JAPAN; METHODOLOGY; MIDDLE AGED; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; ONSET AGE; PATHOLOGY; REPRODUCIBILITY; SPINAL CORD; STATISTICAL MODEL; T LYMPHOCYTE;

ADULT; AGE OF ONSET; ANALYSIS OF VARIANCE; AQUAPORIN 4; AUTOANTIBODIES; BASE SEQUENCE; CASE-CONTROL STUDIES; CELL LINE; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOGLOBULIN G; JAPAN; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; REPRODUCIBILITY OF RESULTS; SPINAL CORD; T-LYMPHOCYTES; TRANSFECTION;

EID: 34249687030     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awm027     Document Type: Article

References (45)

1. Aoki-Yoshino K, Uchihara T, Duyckaerts C, Nakamura A, Hauw J-J, Wakayama Y. Enhanced expression of aquaporin 4 in human brain with inflammatory diseases. Acta Neuropathol 2005; 110: 281-8.
2. Balser BH. Neuromyelitis optica. Brain 1936; 59: 353-65.
3. Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059-69.
4. Cabre P, Signate A, Olindo S, Merle H, Caparros-Lefebvre D, Béra O, et al. Role of return migration in the emergence of multiple sclerosis in the French West Indies. Brain 2005; 128: 2899-910.
5. Chong HT, Ramli N, Lee KH, Kim BJ, Ursekar M, Dayananda K, et al. Magnetic resonance imaging of Asians with multiple sclerosis was similar to that of the West. Neurol Asia 2004; 9: 47-53.
6. Cone W, Russel C, Harwood RU. Lead as a possible cause of multiple sclerosis. Arch Neurol Psychiat 1934; 31: 236-69.
7. Coraddu F, Reyes-Yanez MP, Parra A, Gray J, Smith SI, Taylor CJ, et al. HLA associations with multiple sclerosis in the Canary Islands. J Neuroimmunol 1998; 87: 130-5.
8. Cree BAC, Goodin DS, Hauser SL. Neuromyelitis optica. Semin Neurol 2002; 22: 105-22.
9. Fukazawa T, Hamada T, Tashiro K, Moriwaka F, Yanagihara T. Acute transverse myelopathy in multiple sclerosis. J Neurol Sci 1990; 100: 217-22.
10. Ishizu T, Osoegawa M, Mei F-J, Kikuchi H, Tanaka M, Takakura Y, et al. Interathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 2005; 128: 988-1002.
11. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol 2003; 2: 117-27.
12. Kira J, Kanai T, Nishimura Y, Yamasaki K, Matsushita S, Kawano Y, et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 1996; 40: 569-74.
13. Kira J, Kawano Y, Yamasaki K, Tobimatsu S. Acute myelitis with hyperIgEaemia and mite antigen specific IgE: atopic myelitis. J Neurol Neurosurg Psychiatry 1998; 64: 676-9.
14. Kira J, Yamasaki K, Horiuchi I, Ohyagi Y, Taniwaki T, Kawano Y. Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan. J Neurol Sci 1999; 166: 53-7.
15. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
16. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202: 473-7.
17. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-12.
18. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002; 125: 1450-61.
19. Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, Bollen AW, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 2000; 6: 159-63.
20. Minohara M, Matsuoka T, Li W, Osoegawa M, Ishizu T, Ohyagi Y, et al. Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: positive correlation with disease severity. J Neuroimmunol 2006; 178: 156-60.
21. Misu T, Fujihara K, Nakamura M, Murakami K, Endo M, Konno H, et al. Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J Exp Med 2006; 209: 269-75.
22. Nakashima I, Fujihara K, Miyazawa I, Misu T, Narikawa K, Nakamura M, et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006; 77: 1073-5.
23. Nakashima I, Fujihara K, Takase S, Itoyama Y. Decrease in multiple sclerosis with acute transverse myelitis in Japan. Tohoku J Exp Med 1999; 188: 89-94.
24. Okinaka S, Tsubaki T, Kuroiwa Y, Toyokura Y, Imamura Y, Yoshikawa M. Multiple sclerosis and allied diseases in Japan: clinical characteristics. Neurology 1958; 8: 756-63.
25. Osoegawa M, Ochi H, Kikuchi H, Shirabe S, Nagashima T, Tsumoto T, et al. Eosinophilic myelitis associated with atopic diathesis: a combined neuroimaging and histopathological study. Acta Neuropathol 2003; 105: 289-95.
26. Papadopoulos MC, Manley GT, Krishna S, Verkman AS. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J 2004; 18: 1291-3.
27. Paty DW, Oger JJ, Kastrukoff LF, Hashimoto SA, Hooge JP, Eisen AA, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1988; 38: 180-5.
28. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006a; 63: 390-6.
29. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006b; 63: 964-8.
30. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: gudelines for research protocols. Ann Neurol 1983; 13: 227-31.
31. Saida T, Tashiro K, Itoyama Y, Sato T, Ohashi Y, Zhao Z, et al. Interferon beta-1b is effective in Japanese RRMS patients. A randomised, multicenter study. Neurology 2005; 64: 621-30.
32. Shibasaki H, Kuroiwa Y. Clinical studies of multiple sclerosis in Japan. II. Are its clinical characteristics changing? Neurology 1973; 23: 618-22.
33. Shibasaki H, Kuroda Y, Kuroiwa Y. Clinical studies of multiple sclerosis in Japan: classical multiple sclerosis and Devic's disease. J Neurol Sci 1974; 23: 215-22.
34. Shiraki H, Yamamoto T, Hamada S. Pathoanatomical studies on neuromyelitis optica and demyelinating myelitis in Japan. Seishinshinkeigakuzasshi 1958; 60: 1121-57.
35. Stansbury FC. Neuromyelitis optica (Devic's disease); presentation of five cases, with pathologic study, and review of literature. Arch Ophthalmol 1949; 42: 465-501.
36. Su J-J, Osoegawa M, Matsuoka T, Minohara M, Tanaka M, Ishizu T, et al. Upregulation of vascular growth factors in multiple sclerosis: correlation with MRI findings. J Neurol Sci 2006; 243: 21-30.
37. Tabira T, Tateishi J. Neuropathological features of MS in Japan. In: Kuroiwa Y, Kurland LT, editors. Multiple sclerosis east and west. Fukuoka: Kyushu University Press; 1982. p. 273-95.
38. Tartaglino LM, Friedman DP, Flanders AE, Lublin FD, Knobler RL, Liem M. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 1995; 195: 725-32.
39. Tartaglino LM, Croul SE, Flanders AE, Sweeney JD, Schwartzman RJ, Liem M, et al. Idiopathic acute transverse myelitis: MR imaging findings. Radiology 1996; 201: 661-9.
40. Tomás-Camardiel M, Venero JL, Herrera AJ, De Pablos RM, Pintor-Toro JA, Machado A, et al. Blood-brain barrier disruption highly induces aquaporin-4 mRNA and protein in perivascular and parenchymal astrocytes: protective effect by estradiol treatment in ovariectomized animals. J Neurosci Res 2005; 80: 235-46.
41. Weinshenker BG, Wingerchuk DM, Nakashima I, Fujihara K, Lennon VA. OSMS is NMO, but not MS: proven clinically and pathologically. Lancet Neurol 2006a; 5: 110-1.
42. Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006b; 59: 566-9.
43. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107-14.
44. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-9.
45. Yamasaki K, Horiuchi I, Minohara M, Kawano Y, Ohyagi Y, Yamada T, et al. HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain 1999; 122: 1689-96.